No Data
No Data
Nearshore Protein (688137.SH): intends to use the oversubscribed funds of 72 million yuan to permanently supplement the working capital.
On July 29th, Gelonhui reported that Nearshore Protein (688137.SH) announced that on July 27, 2024, the company held the fourth interim meeting of the second board of directors and the fourth interim meeting of the second supervisory board. It reviewed and approved the Proposal on the Permanent Supplement of Working Capital with Part of the Over-raised Funds, agreed that the company will use RMB 72 million of the over-raised funds to permanently supplement its working capital. The amount of funds to be used for this permanent supplement accounts for 29.73% of the total amount of the over-raised funds.
Nearshore Protein (688137.SH): Annual equity distribution of 10 shares and 5 yuan in 2023, ex-dividend date is August 1.
On July 24th, Gelunhui announced that the company's annual equity distribution plan for 2023 is: based on the total share capital of 70,175,439 shares before the implementation of the plan, a cash dividend of 0.5 yuan (tax inclusive) will be distributed per share, with a total cash dividend of 35,087,719.50 yuan. The equity distribution record date for this distribution is July 31, 2024, and the ex-rights and ex-dividend date is August 1, 2024.
Nearshore protein (688137.SH): Shareholders apologize for violating the commitment to reduce shareholding and promise to buy back.
On July 8th, Gelon Hui announced that it has received a statement on the reduction of Suzhou Nearshore Protein Technology Co., Ltd. shares from Hangzhou Changsui Equity Investment Partnership Enterprise (Limited Partnership) (referred to as "Hangzhou Changsui") and Zibo Jingli Entrepreneurship Investment Partnership Enterprise (Limited Partnership) (referred to as "Zibo Jingli"). The nearshore protein stocks held by Hangzhou Changsui and Zibo Jingli will be lifted on June 26, 2024. On June 20, shareholders of Hangzhou Changsui and Zibo Jingli instructed their staff to prepare for the reduction, while Hangzhou Changsui and Zibo Jingli sold shares on June 6.
About 2.6316 million restricted shares of Nearshore Protein (688137.SH) will be listed for trading starting on June 26.
Jinkan protein (688137.SH) announced that the number of restricted shares to be listed and circulated this time is about 2.6316 million...
Private Companies Among Novoprotein Scientific Inc.'s (SHSE:688137) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 17% Last Week
Near Shore Protein (688137.SH) reported 2023 results, net profit of RMB 12.8436 million, a year-on-year decrease of 85.84%
Near Shore Protein (688137.SH) released its 2023 annual report, achieving operating revenue of 153 million yuan, with...
No Data